Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

NCT01000155 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped The study terminated early due to slow accrual.

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute

Collaborators